Showing results (1671-1680 of 5,702) with videos related to

Sort By:
Pageof 571
The Oncologist|January 7, 2010
Early skin toxicity as a predictive factor for tumor control in hepatocellular carcinoma patients treated with sorafenibBruno Vincenzi, Daniele Santini, Antonio Russo, et al.
The Oncologist|November 30, 2005
Adjuvant chemotherapy for early breast cancer: optimal use of epirubicinStefan Glück
The Oncologist|November 30, 2005
When prostate brachytherapy fails: a case report and discussionCigall Kadoch, Anthony V D'Amico, Richard H Matthews
The Oncologist|November 30, 2005
ET-743: a novel agent with activity in soft tissue sarcomasJérôme Fayette, Isabelle Ray Coquard, Laurent Alberti, et al.
The Oncologist|November 30, 2005
Using single-agent therapy in adult patients with advanced soft tissue sarcoma can still be considered standard careStefan Sleijfer, Caroline Seynaeve, Jaap Verweij
The Oncologist|October 27, 2005
Topotecan as second-line therapy for ovarian cancer: dosage versus toxicityMaurie Markman
The Oncologist|October 27, 2005
Topotecan: weighing in when there are many optionsRichard T Penson, Michael V Seiden
The Oncologist|October 27, 2005
Helping melanoma patients decide whether to choose adjuvant high-dose interferon-alpha2bKaren E Hurley, Paul B Chapman
The Oncologist|December 8, 2009
A case of bullous dermatitis induced by erlotinibAlessandro Oteri, Maria Teresa Cattaneo, Virginio Filipazzi, et al.
The Oncologist|January 14, 2010
The evolving role of monoclonal antibodies in colorectal cancer: early presumptions and impact on clinical trial developmentCathy Eng
Pageof 571